Xtant Medical Holdings, Inc. Cash Flow Statement
XTNT|15 years of annual SEC 10-K data (FY2011-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 15 fiscal years. All figures from audited SEC 10-K filings.
Xtant Medical Holdings, Inc. used $12M in operating cash flow and negative free cash flow of $16M in FY2025.
Based on SEC 10-K filings.
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$16.4M | $660.0K | -$8.5M | -$4.8M | -$7.0M | -$8.2M | -$70.1M | -$52.4M | -$19.5M | -$2.2M | -$10.5M | -$12.7M | -$7.7M | -$3.0M | -$19.5M |
| Depreciation & Amortization | $4.2M | $3.2M | $1.3M | $1.3M | $2.1M | $3.1M | $6.6M | $8.4M | $7.2M | $4.9M | $952.3K | $753.5K | $782.9K | $755.4K | $682.5K |
| Operating Cash Flow | -$11.9M | -$9.5M | -$5.3M | $439.0K | -$731.0K | -$413.0K | $1.2M | -$543.0K | -$14.4M | -$9.1M | -$7.3M | -$4.9M | -$10.8M | -$7.4M | -$8.4M |
| Capital Expenditures | $4.1M | $1.5M | $1.8M | $2.1M | $1.5M | $879.0K | $624.0K | $1.6M | $5.8M | $2.3M | $300.0K | $623.0K | $1.8M | $962.3K | $783.1K |
| Free Cash Flow | -$16.0M | -$11.0M | -$7.1M | -$1.7M | -$2.3M | -$1.3M | $588.0K | -$2.2M | -$20.2M | -$11.4M | -$7.6M | -$5.5M | -$12.6M | -$8.3M | -$9.2M |
| Share Buybacks | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $726.7K |
| FCF Margin | -13.7% | -12.0% | -12.3% | -3.0% | -4.3% | -2.0% | 0.8% | -2.6% | -22.5% | -19.1% | -21.6% | -16.7% | -38.3% | -27.6% | -59.4% |